{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:52:46Z","timestamp":1773834766007,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.thromres.2013.10.007","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T06:46:05Z","timestamp":1381560365000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Thromboelastography Identifies Hypercoagulablilty and Predicts Thromboembolic Complications in Patients with Prostate Cancer"],"prefix":"10.1016","volume":"133","author":[{"given":"Mazen","family":"Toukh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Robert","family":"Siemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Leveridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.10.007_bb0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case\u2013control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2013.10.007_bb0010","first-page":"127","article-title":"Evaluation for cancer in patients with symptomatic DVT","volume":"44","author":"Bergus","year":"1997","journal-title":"J Fam Pract"},{"key":"10.1016\/j.thromres.2013.10.007_bb0015","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2013.10.007_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3988\/jcn.2009.5.4.195","article-title":"A case of cerebral venous thrombosis as the presenting sign of occult prostate cancer","volume":"5","author":"Lee","year":"2009","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2011.5196","article-title":"Pulmonary embolus as a first presentation of occult metastatic prostate cancer","volume":"2012","author":"Mukherjee","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.thromres.2013.10.007_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2009.04.012","article-title":"Testing for occult cancer in patients with pulmonary embolism: results from a screening program and a two-year follow-up survey","volume":"125","author":"Jara-Palomares","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.10.007_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(10)70038-3","article-title":"Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden","volume":"11","author":"Van Hemelrijck","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/asheducation-2010.1.144","article-title":"Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants","volume":"2010","author":"Lee","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.thromres.2013.10.007_bb0045","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","article-title":"American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer","volume":"25","author":"Lyman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2013.10.007_bb0055","first-page":"465","article-title":"Risk of the \"androgen deprivation syndrome\" in men receiving androgen deprivation for prostate cancer","volume":"166","author":"Shahinian","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2013.10.007_bb0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1634\/theoncologist.12-11-1361","article-title":"The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients","volume":"12","author":"Khorana","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.thromres.2013.10.007_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0037-1613558","article-title":"Correlates of thrombin generation in patients with advanced prostate cancer","volume":"89","author":"Lind","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.007_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001721-200201000-00001","article-title":"Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer","volume":"13","author":"Kohli","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2013.10.007_bb0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/asheducation.V2012.1.626.3798655","article-title":"Cancer-associated thrombosis: updates and controversies","volume":"2012","author":"Khorana","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.thromres.2013.10.007_bb0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1160\/TH12-07-0508","article-title":"The use of weighted and scored risk assessment models for venous thromboembolism","volume":"108","author":"Spyropoulos","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.007_bb0085","first-page":"286","article-title":"Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer","volume":"9","author":"Saphner","year":"1991","journal-title":"Cancer Clin Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0090","doi-asserted-by":"crossref","first-page":"394740","DOI":"10.4061\/2011\/394740","article-title":"Arterial and venous thrombosis in cancer patients","volume":"2011","author":"Blann","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.thromres.2013.10.007_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20020209","article-title":"Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia","volume":"104","author":"Dockery","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.thromres.2013.10.007_bb0100","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF01697545","volume":"26","author":"Hartert","year":"1948","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.thromres.2013.10.007_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12032-008-9129-0","article-title":"Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography","volume":"26","author":"Akay","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0049-3848(94)90149-X","article-title":"Assessment of hypercoagulability in patients with cancer using the Sonoclot Analyzer and thromboelastography","volume":"74","author":"Francis","year":"1994","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.10.007_bb0120","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1213\/01.ANE.0000155290.86795.12","article-title":"Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction","volume":"100","author":"McCrath","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.thromres.2013.10.007_bb0125","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2009.22.6324","article-title":"Role of tissue factor in cancer","volume":"27","author":"Kasthuri","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2119\/2003-00047.Versteeg","article-title":"Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways","volume":"10","author":"Versteeg","year":"2004","journal-title":"Mol Med"},{"key":"10.1016\/j.thromres.2013.10.007_bb0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.thromres.2009.09.019","article-title":"Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism","volume":"125","author":"Manly","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.10.007_bb0140","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.10.007_bb0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10544-012-9642-y","article-title":"Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics","volume":"14","author":"Ashcroft","year":"2012","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.thromres.2013.10.007_bb0150","first-page":"e111","article-title":"Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment","volume":"12","author":"Rice","year":"2010","journal-title":"Rev Urol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0155","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1002\/cncr.26623","article-title":"Androgen deprivation and thromboembolic events in men with prostate cancer","volume":"118","author":"Ehdaie","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2013.10.007_bb0160","first-page":"3300","article-title":"Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin","volume":"54","author":"Yoshida","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.thromres.2013.10.007_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2003-40968","article-title":"Role of coagulation and fibrinolytic system in prostate cancer","volume":"29","author":"Kohli","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.10.007_bb0170","first-page":"69","article-title":"Coagulation and fibrinolysis activation markers in prostatic carcinoma patients","volume":"35","author":"Geenen","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.thromres.2013.10.007_bb0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1538-7836.2004.00682.x","article-title":"Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice","volume":"2","author":"Reijerkerk","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.10.007_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/03091900903402071","article-title":"Role of thrombelastograph haemostasis analyser in detection of hypercoagulability following surgery with and without use of intermittent pneumatic compression","volume":"34","author":"Lee","year":"2010","journal-title":"J Med Eng Technol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MBC.0b013e3283358179","article-title":"Comparative assessment of hypercoagulability in women with and without gynecologic malignancies using the thromboelastograph coagulation analyzer","volume":"21","author":"Wehrum","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2013.10.007_bb0190","first-page":"69","article-title":"Recurrent ischemic strokes secondary to acquired hypercoagulability in a patient with prostatic adenocarcinoma","volume":"19","author":"Amela","year":"2004","journal-title":"Neurologia"},{"key":"10.1016\/j.thromres.2013.10.007_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/713604715","article-title":"Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness","volume":"5","author":"Dockery","year":"2002","journal-title":"Aging Male"},{"key":"10.1016\/j.thromres.2013.10.007_bb0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2164\/jandrol.108.006924","article-title":"Effect of androgen suppression compared with androgen receptor blockade on arterial stiffness in men with prostate cancer","volume":"30","author":"Dockery","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.thromres.2013.10.007_bb0205","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-4295(03)00768-4","article-title":"Tissue factor expression and prognosis in patients with metastatic prostate cancer","volume":"62","author":"Akashi","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.thromres.2013.10.007_bb0210","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/carcin\/bgg039","article-title":"Tissue factor signal transduction in angiogenesis","volume":"24","author":"Versteeg","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.thromres.2013.10.007_bb0215","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/annonc\/mds073","article-title":"Predicting and accounting for VTE in phase I cancer studies","volume":"23","author":"Khorana","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thromres.2013.10.007_bb0220","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813004647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813004647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T22:03:00Z","timestamp":1596664980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813004647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0049384813004647"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.10.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboelastography Identifies Hypercoagulablilty and Predicts Thromboembolic Complications in Patients with Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}